+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Pharmacyclics llc - logo

Pharmacyclics LLC focuses on developing novel therapies for the treatment of cancer and immune-mediated diseases in the United States. The company markets IMBRUVICA, a single-agent therapy used for the treatment of patients with chronic lymphocytic leukemia, mantle cell lymphoma and waldenström's macroglobulinemia. It also has several product candidates in clinical development. The company was founded in 1991 and is headquartered in Sunnyvale, California.

From
From
From
From
From
From
From
From
From
From
From
From
From
Aplastic Anemia - Pipeline Insight, 2019 - Product Thumbnail Image

Aplastic Anemia - Pipeline Insight, 2019

  • Drug Pipelines
  • 50 Pages
From
Factor VIIa Inhibitor -Pipeline Insight, 2019 - Product Thumbnail Image

Factor VIIa Inhibitor -Pipeline Insight, 2019

  • Drug Pipelines
  • 60 Pages
From
From
From
From
Rheumatoid Arthritis - Pipeline Review, H2 2017 - Product Thumbnail Image

Rheumatoid Arthritis - Pipeline Review, H2 2017

  • Drug Pipelines
  • 1051 Pages
From
Loading Indicator
adroll